$NKLA
Nikola Corp

2021 Q1 Form 10-Q Financial Statement

#000173128921000071 Filed on May 07, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $0.00 $58.00K
YoY Change -100.0% -53.23%
Cost Of Revenue $0.00 $43.00K
YoY Change -100.0% -30.65%
Gross Profit $0.00 $15.00K
YoY Change -100.0% -75.81%
Gross Profit Margin 25.86%
Selling, General & Admin $65.43M $7.935M
YoY Change 724.54% 22.06%
% of Gross Profit 52900.0%
Research & Development $55.16M $24.08M
YoY Change 129.11% 2.91%
% of Gross Profit 160513.33%
Depreciation & Amortization $1.805M $1.408M
YoY Change 28.2%
% of Gross Profit 9386.67%
Operating Expenses $120.6M $32.01M
YoY Change 276.7% 7.07%
Operating Profit -$120.6M -$32.00M
YoY Change 276.88% 7.24%
Interest Expense -$9.000K $62.00K
YoY Change -114.52% -81.38%
% of Operating Profit
Other Income/Expense, Net $219.0K $114.0K
YoY Change 92.11% 11300.0%
Pretax Income -$119.4M -$33.15M
YoY Change 260.32% 10.13%
Income Tax $1.000K $1.000K
% Of Pretax Income
Net Earnings -$120.2M -$33.15M
YoY Change 262.71% 10.13%
Net Earnings / Revenue -57148.28%
Basic Earnings Per Share -$0.31 -$0.12
Diluted Earnings Per Share -$0.31 -$0.12
COMMON SHARES
Basic Shares Outstanding 392.2M shares 271.9M shares
Diluted Shares Outstanding 392.5M shares 271.9M shares

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $763.8M $1.200M
YoY Change 63550.0% 33.33%
Cash & Equivalents $763.8M $75.52M
Short-Term Investments
Other Short-Term Assets $40.60M $0.00
YoY Change -100.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $804.4M $1.200M
YoY Change 66932.92% 20.0%
LONG-TERM ASSETS
Property, Plant & Equipment $123.4M
YoY Change
Goodwill $5.238M
YoY Change
Intangibles $50.00M
YoY Change
Long-Term Investments $7.312M
YoY Change
Other Assets $0.00 $238.4M
YoY Change -100.0% 0.76%
Total Long-Term Assets $198.9M $238.3M
YoY Change -16.52% 0.72%
TOTAL ASSETS
Total Short-Term Assets $804.4M $1.200M
Total Long-Term Assets $198.9M $238.3M
Total Assets $1.003B $239.5M
YoY Change 318.92% 0.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $40.80M $100.0K
YoY Change 40700.0% 0.0%
Accrued Expenses $29.00M $100.0K
YoY Change 28900.0% -50.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $400.0K
YoY Change -100.0%
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $70.97M $1.300M
YoY Change 5359.31% 18.18%
LONG-TERM LIABILITIES
Long-Term Debt $13.70M $0.00
YoY Change
Other Long-Term Liabilities $6.400M
YoY Change
Total Long-Term Liabilities $20.10M $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $70.97M $1.300M
Total Long-Term Liabilities $20.10M $0.00
Total Liabilities $91.04M $1.300M
YoY Change 6902.69% 8.33%
SHAREHOLDERS EQUITY
Retained Earnings -$680.4M
YoY Change
Common Stock $39.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $912.3M $193.5M
YoY Change
Total Liabilities & Shareholders Equity $1.003B $239.5M
YoY Change 318.92% 0.8%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income -$120.2M -$33.15M
YoY Change 262.71% 10.13%
Depreciation, Depletion And Amortization $1.805M $1.408M
YoY Change 28.2%
Cash From Operating Activities -$59.25M -$21.90M
YoY Change 170.58% 7199.0%
INVESTING ACTIVITIES
Capital Expenditures -$24.52M
YoY Change
Acquisitions
YoY Change
Other Investing Activities $238.9M
YoY Change -597300.0%
Cash From Investing Activities -$24.52M -$1.439M
YoY Change 1604.03% 3497.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $12.96M
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$1.758M $13.15M
YoY Change -113.37%
NET CHANGE
Cash From Operating Activities -$59.25M -$21.90M
Cash From Investing Activities -$24.52M -$1.439M
Cash From Financing Activities -$1.758M $13.15M
Net Change In Cash -$85.53M -$10.19M
YoY Change 739.74% 2895.59%
FREE CASH FLOW
Cash From Operating Activities -$59.25M -$21.90M
Capital Expenditures -$24.52M
Free Cash Flow -$34.73M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001731289
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
us-gaap:AccountingStandardsUpdate201602Member
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
001-38495
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
Nikola Corporation
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-4151153
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
4141 E Broadway Road
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Phoenix
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85040
CY2021Q1 dei City Area Code
CityAreaCode
480
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
666-1038
CY2021Q1 dei Security12b Title
Security12bTitle
Common stock, $0.0001 par value per share
CY2021Q1 dei Trading Symbol
TradingSymbol
NKLA
CY2021Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
393848491 shares
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
763750000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
840913000 USD
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
0 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
4365000 USD
CY2021Q1 nkla Prepaid In Kind Services Current
PrepaidInKindServicesCurrent
33375000 USD
CY2020Q4 nkla Prepaid In Kind Services Current
PrepaidInKindServicesCurrent
46271000 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7270000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5368000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
804395000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
896917000 USD
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
0 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
4000000 USD
CY2021Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
12951000 USD
CY2020Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
17687000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
123422000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
71401000 USD
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
50000000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
50050000 USD
CY2021Q1 us-gaap Equity Method Investments
EquityMethodInvestments
7312000 USD
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
8420000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
5238000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
5238000 USD
CY2021Q1 us-gaap Assets
Assets
1003318000 USD
CY2020Q4 us-gaap Assets
Assets
1053713000 USD
CY2021Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
40827000 USD
CY2020Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
29364000 USD
CY2021Q1 nkla Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
30144000 USD
CY2020Q4 nkla Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
18809000 USD
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
4100000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
70971000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
52273000 USD
CY2021Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
13671000 USD
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
13956000 USD
CY2021Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
6384000 USD
CY2020Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
7335000 USD
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
9000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
8000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
91035000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
73572000 USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
150000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
150000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
393745157 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
393745157 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
391041347 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
391041347 shares
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
39000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
39000 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1592716000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1540037000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-74000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
239000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-680398000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-560174000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
912283000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
980141000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1003318000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1053713000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
58000 USD
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
0 USD
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
43000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
0 USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
15000 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
55163000 USD
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24077000 USD
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
65427000 USD
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7935000 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
120590000 USD
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
32012000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-120590000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-31997000 USD
CY2021Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-9000 USD
CY2020Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
62000 USD
CY2021Q1 nkla Gain Loss On Financial Instruments Subject To Mandatory Redemption
GainLossOnFinancialInstrumentsSubjectToMandatoryRedemption
0 USD
CY2020Q1 nkla Gain Loss On Financial Instruments Subject To Mandatory Redemption
GainLossOnFinancialInstrumentsSubjectToMandatoryRedemption
-1324000 USD
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-951000 USD
CY2020Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
219000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
114000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-119429000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-33145000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000 USD
CY2021Q1 nkla Income Loss From Continuing Operations Before Equity Method Investments Noncontrolling Interest Net Of Tax
IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterestNetOfTax
-119430000 USD
CY2020Q1 nkla Income Loss From Continuing Operations Before Equity Method Investments Noncontrolling Interest Net Of Tax
IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterestNetOfTax
-33146000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-794000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-120224000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-33146000 USD
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
392189851 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
271896258 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
392489761 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
271896258 shares
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-120224000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-33146000 USD
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-313000 USD
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
0 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-120537000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-33146000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
980141000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2413000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
50266000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-120224000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-313000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
912283000 USD
CY2019Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2019Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
195508000 USD
CY2020Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2651000 USD
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10677000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
20000000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1313000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-33146000 USD
CY2020Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2020Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
193526000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-120224000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-33146000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1805000 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1408000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
50266000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1313000 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1000 USD
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1000 USD
CY2021Q1 nkla Non Cash In Kind Services
NonCashInKindServices
12896000 USD
CY2020Q1 nkla Non Cash In Kind Services
NonCashInKindServices
6731000 USD
CY2021Q1 nkla Gain Loss On Financial Instruments Subject To Mandatory Redemption
GainLossOnFinancialInstrumentsSubjectToMandatoryRedemption
0 USD
CY2020Q1 nkla Gain Loss On Financial Instruments Subject To Mandatory Redemption
GainLossOnFinancialInstrumentsSubjectToMandatoryRedemption
-1324000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-794000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-951000 USD
CY2020Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-323000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1758000 USD
CY2020Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-314000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2083000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-156000 USD
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4161000 USD
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0 USD
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
0 USD
CY2020Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-9000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-59249000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21897000 USD
CY2021Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
24521000 USD
CY2020Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
1439000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-24521000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1439000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12963000 USD
CY2021Q1 nkla Proceeds From Recapitalization Transaction
ProceedsFromRecapitalizationTransaction
0 USD
CY2020Q1 nkla Proceeds From Recapitalization Transaction
ProceedsFromRecapitalizationTransaction
-394000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
2626000 USD
CY2020Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
2000 USD
CY2021Q1 nkla Proceeds From Finance Lease
ProceedsFromFinanceLease
0 USD
CY2020Q1 nkla Proceeds From Finance Lease
ProceedsFromFinanceLease
889000 USD
CY2021Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
258000 USD
CY2020Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
309000 USD
CY2021Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
4100000 USD
CY2020Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
0 USD
CY2021Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
26000 USD
CY2020Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1758000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13151000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-85528000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10185000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
849278000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
89832000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
763750000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
79647000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
187000 USD
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
282000 USD
CY2021Q1 nkla Interest Received
InterestReceived
259000 USD
CY2020Q1 nkla Interest Received
InterestReceived
310000 USD
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
27108000 USD
CY2020Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3584000 USD
CY2021Q1 nkla Accrued Deferred Issuance Costs
AccruedDeferredIssuanceCosts
330000 USD
CY2020Q1 nkla Accrued Deferred Issuance Costs
AccruedDeferredIssuanceCosts
0 USD
CY2021Q1 nkla Accrued Proceeds From Issuance Or Sale Of Temporary Equity
AccruedProceedsFromIssuanceOrSaleOfTemporaryEquity
0 USD
CY2020Q1 nkla Accrued Proceeds From Issuance Or Sale Of Temporary Equity
AccruedProceedsFromIssuanceOrSaleOfTemporaryEquity
6868000 USD
CY2021Q1 nkla Noncash Prepaid In Kind Services
NoncashPrepaidInKindServices
0 USD
CY2020Q1 nkla Noncash Prepaid In Kind Services
NoncashPrepaidInKindServices
13269000 USD
CY2021Q1 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
0 USD
CY2020Q1 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
4263000 USD
CY2020Q1 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
4263000 USD
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
763800000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
840900000 USD
CY2021Q1 us-gaap Deposits
Deposits
0 USD
CY2020Q4 us-gaap Deposits
Deposits
300000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
763750000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
840913000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
75515000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
85688000 USD
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
0 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
4365000 USD
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
4132000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
0 USD
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
0 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
4000000 USD
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
0 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
4144000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
763750000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
849278000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
79647000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
89832000 USD
CY2021Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
6384000 USD
CY2020Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
7335000 USD
CY2021Q1 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P4Y2M4D
CY2020Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P4Y5M1D
CY2020Q2 nkla Conversion Of Stock Shares Issued Conversion Rate
ConversionOfStockSharesIssuedConversionRate
1.901
CY2020Q2 nkla Common Stock And Preferred Stock Shares Authorized
CommonStockAndPreferredStockSharesAuthorized
750000000 shares
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
150000000 shares
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q2 nkla Shares Issued During Period Shares Recapitalization
SharesIssuedDuringPeriodSharesRecapitalization
72272942 shares
CY2020Q2 nkla Common Stock Shares Outstanding Prior To Conversion
CommonStockSharesOutstandingPriorToConversion
288631536 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
360904478 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
151831441 shares
CY2020Q2 nkla Conversion Of Stock Shares Issued Conversion Rate
ConversionOfStockSharesIssuedConversionRate
1.901
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
133592000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
79816000 USD
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10170000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8415000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
123422000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
71401000 USD
CY2021Q1 us-gaap Depreciation
Depreciation
1800000 USD
CY2020Q1 us-gaap Depreciation
Depreciation
1400000 USD
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8149000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1105000 USD
CY2021Q1 nkla Accrued Stock Issuance Costs Current
AccruedStockIssuanceCostsCurrent
615000 USD
CY2020Q4 nkla Accrued Stock Issuance Costs Current
AccruedStockIssuanceCostsCurrent
285000 USD
CY2021Q1 nkla Accrued Outsourced Engineering Services Current
AccruedOutsourcedEngineeringServicesCurrent
4058000 USD
CY2020Q4 nkla Accrued Outsourced Engineering Services Current
AccruedOutsourcedEngineeringServicesCurrent
2514000 USD
CY2021Q1 nkla Accrued Purchases Of Property And Equipment Current
AccruedPurchasesOfPropertyAndEquipmentCurrent
4310000 USD
CY2020Q4 nkla Accrued Purchases Of Property And Equipment Current
AccruedPurchasesOfPropertyAndEquipmentCurrent
2533000 USD
CY2021Q1 nkla Accrued Legal Liabilities Current
AccruedLegalLiabilitiesCurrent
9813000 USD
CY2020Q4 nkla Accrued Legal Liabilities Current
AccruedLegalLiabilitiesCurrent
8845000 USD
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2102000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2457000 USD
CY2021Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1097000 USD
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1070000 USD
CY2021Q1 nkla Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
30144000 USD
CY2020Q4 nkla Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
18809000 USD
CY2021Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
50150000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
150000 USD
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
50000000 USD
CY2020Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
50150000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
100000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
50050000 USD
CY2019Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0300
CY2021Q1 nkla Common Stock And Preferred Stock Shares Authorized
CommonStockAndPreferredStockSharesAuthorized
750000000 shares
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
32599 shares
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
150000000 shares
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-950000 USD
CY2020Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2021Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
6400000 USD
CY2020Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
7300000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
42802865 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
32529224 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.28
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y9M25D
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1896667 shares
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.27
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
3.18
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
30599958 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.28
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M7D
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
29622290 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.23
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y5M26D
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
50266000 USD
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1313000 USD
CY2021Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
401627000 USD
CY2020Q3 nkla Number Of Class Action Lawsuits
NumberOfClassActionLawsuits
6 lawsuit
CY2020Q3 nkla Number Of Derivative Actions
NumberOfDerivativeActions
2 derivativeAction
CY2020Q4 nkla Period Of Derivative Action
PeriodOfDerivativeAction
P30D
CY2021Q1 nkla Period Of Derivative Action
PeriodOfDerivativeAction
P30D
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-120224000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-33146000 USD
CY2021Q1 us-gaap Dilutive Securities
DilutiveSecurities
951000 USD
CY2020Q1 us-gaap Dilutive Securities
DilutiveSecurities
0 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-121175000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-121175000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-33146000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-33146000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
392189851 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
271896258 shares
CY2021Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
299910 shares
CY2020Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
392489761 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
271896258 shares
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
50958970 shares
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
41084216 shares

Files In Submission

Name View Source Status
0001731289-21-000071-index-headers.html Edgar Link pending
0001731289-21-000071-index.html Edgar Link pending
0001731289-21-000071.txt Edgar Link pending
0001731289-21-000071-xbrl.zip Edgar Link pending
exhibit311q121.htm Edgar Link pending
exhibit312q121.htm Edgar Link pending
exhibit321q121.htm Edgar Link pending
exhibit322q121.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nkla-20210331.htm Edgar Link pending
nkla-20210331.xsd Edgar Link pending
nkla-20210331_cal.xml Edgar Link unprocessable
nkla-20210331_def.xml Edgar Link unprocessable
nkla-20210331_htm.xml Edgar Link completed
nkla-20210331_lab.xml Edgar Link unprocessable
nkla-20210331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending